跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MIDODRINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MIDODRINE
Authorized
STANDARD
MIDODRINE
sanis health inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b14ab4e51ed20c4c
Company
sanis health inc
Type
Standard
Approval Details
Approval Id
b14ab4e51ed20c4c
Drug Approval Canada Name
MIDODRINE
Product Name
MIDODRINE
Status
Marketed
Status Date
2023-05-31
Original Market Date
2023-05-31
Din
02533200
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
12:12.04
Atc Original
C01CA17 MIDODRINE
Atc Name
c 01 ca 17
Aig Number
0123066001
Company Name
sanis health inc
Company Address
1 Presidents Choice Circle, Brampton, Ontario, Canada, L6Y 5S5
Active Ingredients
MIDODRINE HYDROCHLORIDE
2.5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b14ab4e51ed20c4c
Type
Standard
Back to Health Canada Approvals